Position in NVO
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,618,166
+$387,446 QoQ
Shares Held
33,754
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#418
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BENEDICT FINANCIAL ADVISORS INC holds $49,408,945 across 8 Drug Manufacturers - General names. NVO ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,991 | $15,489,884 | |
| 2 | AMGN |
Amgen Inc
|
33,255 | $12,042,300 | |
| 3 | ABBV |
AbbVie Inc.
|
47,038 | $11,836,642 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
70,088 | $4,038,470 | |
| 5 | NVS |
Novartis AG
|
17,055 | $2,672,859 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
33,754 | $1,618,166 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,812 | $1,492,328 | |
| 8 | LLY |
ELI LILLY & Co
|
182 | $218,296 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,618,166 | 33,754 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,230,720 | 33,489 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,807,613 | 35,527 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,984,544 | 35,764 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,492,519 | 36,113 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,621,846 | 37,757 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,316,157 | 38,551 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $4,770,539 | 40,065 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $5,909,150 | 41,398 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $5,475,746 | 42,646 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $4,517,040 | 43,664 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $4,027,914 | 44,292 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $3,695,388 | 22,835 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,688,706 | 23,179 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,335,048 | 24,642 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,490,451 | 24,997 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,803,133 | 25,156 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $2,816,783 | 25,365 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $2,867,200 | 25,600 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,522,758 | 26,276 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,229,789 | 26,618 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,725,277 | 25,590 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,750,510 | 25,061 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,681,664 | 24,221 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,550,042 | 23,672 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $1,301,524 | 21,620 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||